EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, HST Global's Enterprise Value is $5.87 Mil.
HST Global's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.02 Mil. Therefore, HST Global's EV-to-FCF for today is -293.50.
The historical rank and industry rank for HST Global's EV-to-FCF or its related term are showing as below:
HSTC'
s EV-to-FCF Range Over the Past 10 Years
Min: -298.75 Med: 0 Max: 0
Current: -293.5
HSTC's EV-to-FCF is ranked worse than 100% of 390
companies
in the Biotechnology industry
Industry Median: 6.365
vs HSTC: -293.50
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-05-11), HST Global's stock price is $1.10.
HST Global's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.040. Therefore, HST Global's PE Ratio for today is At Loss.
HST Global EV-to-FCF Historical Data
The historical data trend for HST Global's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, HST Global's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HST Global's EV-to-FCF Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, HST Global's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where HST Global's EV-to-FCF falls into.
HST Global EV-to-FCF Calculation
HST Global's EV-to-FCF for today is calculated as:
HST Global's current Enterprise Value is $5.87 Mil.
HST Global's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HST Global (OTCPK:HSTC) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
HST Global's share price for today is $1.10.
HST Global's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.040.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
HST Global EV-to-FCF Related Terms
Thank you for viewing the detailed overview of HST Global's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
HST Global Inc is an integrated health and wellness biotechnology company. It is engaged in developing and acquiring a network of Wellness Centers that are focused on the homeopathic and alternative treatment of late-stage cancer. Further, it primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing. The activities are generally carried out through the region of the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HSTC has been successfully added to your 